ZFAS1 and hepatocellular carcinoma: In cancers, ZFAS1 is thought to be overexpressed in most human cancers, including nonsmall cell lung cancer (Ge et al., 2020), colorectal cancer (Wu et al., 2020), glioma (Li et al., 2020), hepatocellular carcinoma (Liang et al., 2019) and head and neck cancer (Kolenda et al., 2019).